Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
1.5800 x 1 1.6200 x 15
Post-market by (Cboe BZX)
1.5800 +0.0500 (+3.27%) 04/23/25 [NASDAQ]
1.5800 x 1 1.6200 x 15
Post-market 1.5800 unch (unch) 16:15 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5400
Day High
1.6100
Open 1.5400
Previous Close 1.5300 1.5300
Volume 150,300 150,300
Avg Vol 209,380 209,380
Stochastic %K 67.41% 67.41%
Weighted Alpha -28.84 -28.84
5-Day Change +0.0600 (+3.95%) +0.0600 (+3.95%)
52-Week Range 1.3300 - 2.8900 1.3300 - 2.8900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,187
  • Shares Outstanding, K 29,534
  • Annual Sales, $ 57,680 K
  • Annual Income, $ -46,000 K
  • EBIT $ -107 M
  • EBITDA $ -98 M
  • 60-Month Beta 1.82
  • Price/Sales 0.77
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 198.04% ( -110.84%)
  • Historical Volatility 54.11%
  • IV Percentile 62%
  • IV Rank 23.43%
  • IV High 751.82% on 01/17/25
  • IV Low 28.61% on 07/17/24
  • Put/Call Vol Ratio 1.11
  • Today's Volume 19
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 1,427
  • Open Int (30-Day) 3,964

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.44
  • Number of Estimates 1
  • High Estimate -0.44
  • Low Estimate -0.44
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +57.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3300 +18.80%
on 04/09/25
Period Open: 1.7100
1.7800 -11.24%
on 03/25/25
-0.1300 (-7.60%)
since 03/21/25
3-Month
1.3300 +18.80%
on 04/09/25
Period Open: 1.8200
2.0000 -21.00%
on 02/06/25
-0.2400 (-13.19%)
since 01/23/25
52-Week
1.3300 +18.80%
on 04/09/25
Period Open: 1.8100
2.8900 -45.33%
on 07/23/24
-0.2300 (-12.71%)
since 04/23/24

Most Recent Stories

More News
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

FBIO : 1.5800 (+3.27%)
FBIOP : 6.45 (+3.70%)
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

FBIO : 1.5800 (+3.27%)
CKPT : 4.04 (unch)
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform

FBIO : 1.5800 (+3.27%)
FBIOP : 6.45 (+3.70%)
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO : 1.5800 (+3.27%)
MBIO : 1.3294 (+7.21%)
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

FBIO : 1.5800 (+3.27%)
DERM : 7.48 (+1.22%)

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

3rd Resistance Point 1.6833
2nd Resistance Point 1.6467
1st Resistance Point 1.6133
Last Price 1.5800
1st Support Level 1.5433
2nd Support Level 1.5067
3rd Support Level 1.4733

See More

52-Week High 2.8900
Fibonacci 61.8% 2.2941
Fibonacci 50% 2.1100
Fibonacci 38.2% 1.9259
Last Price 1.5800
52-Week Low 1.3300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective